Ovid Therapeutics Inc.

NASDAQ:OVID

Biotechnology

Healthcare
$2.34 -4.34%

-$0.11 today

Market cap
$441.63M
Beta
0.18
P/E (TTM)
-7.1
EPS (TTM)
-$0.33
52W Low $0.29High $3.11

Volume 1.77M

Average 3.07M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$38.33M

FY 2025 · Annual

Investing Cash Flow

-$49.85M

FY 2025 · Annual

Financing Cash Flow

$75.21M

FY 2025 · Annual

+11991.2% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income119.84M(54.17M)(52.34M)(26.43M)(17.41M)
Depreciation & Amortization237K1.38M1.6M613K273K
Deferred Income Tax00000
Stock-Based Compensation06.56M7.29M6.28M4.81M
Change in Working Capital(16.81M)(8.23M)2.39M(150K)(4.1M)
Accounts Receivables141.76K0000
Inventory00000
Accounts Payables1.7M(5.17M)1.75M(512K)(1.23M)
Other Working Capital(18.66M)(3.06M)635.51K362K(2.87M)
Other Non-Cash Items15.35M(764.94K)(4.71M)(36.26M)(21.9M)
Operating Cash Flow118.61M(55.23M)(45.78M)(55.96M)(38.33M)
Capital Expenditures(189.41K)(1.42M)(137.46K)(71K)0
Acquisitions (Net)(1.63M)(2.5M)(10M)00
Purchases of Investments(1.63M)(172.96M)(112.44M)(73.25M)(91.85M)
Sales of Investments090M120M128M42M
Other Investing Activities(5.4K)(1M)(97.15K)(89K)0
Investing Cash Flow(1.82M)(87.88M)(2.58M)54.59M(49.85M)
Debt Repayment0030M00
Common Stock Issued925.4K180.66K535.2K622K75.21M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(21.31K)0000
Financing Cash Flow904.08K180.66K30.54M622K75.21M
Effect of Forex Changes(1.93M)000(167K)
Net Change in Cash115.76M(142.93M)(17.83M)(740K)(13.15M)
Free Cash Flow118.42M(56.65M)(45.92M)(56.03M)(38.33M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$17.4M
+ D&A$273.0K
+ Stock-Based Comp$4.8M
+ Deferred Tax$0
- Working Capital-$4.1M
- Other Non-Cash-$21.9M
= Operating Cash Flow-$38.3M
- Capex$0
= Free Cash Flow-$38.3M

Analysis

FY2025 free cash flow is -$38.3M. FCF conversion is 220.1% of net income. Operating cash flow was -$38.3M, with capex of $0. The largest bridge item is Other Non-Cash at -$21.9M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
S-3S-3 filingNov 10, 2026
10-QQuarterly reportNov 10, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

Does OVID generate free cash flow?

Ovid Therapeutics Inc. (OVID) generated -$38.33M of free cash flow in fiscal 2025.

How much operating cash flow does OVID produce?

Operating cash flow was -$38.33M, before capital expenditures of $0.00.